PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 12, 2010, Pages 2274-2285

  Kurzawa, Laetitia ^a   Pellerano, Morgan ^a   Morris, May C ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Cell penetrating peptide carrier; Delivery; Fluorescence; Imaging; Interaction

Indexed keywords

CADY PEPTIDE; CADY2 PEPTIDE; CELL PENETRATING PEPTIDE; DRUG CARRIER; MP51 PEPTIDE; NANOPARTICLE; NANOTUBE; PEP1 PEPTIDE; PEP2 PEPTIDE; PEP3 PEPTIDE; PROTEIN; RED FLUORESCENT PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACETYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL CYCLE PROGRESSION; CELL TRANSPORT; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; DRUG LABELING; DRUG PROTEIN BINDING; HUMAN; HYDROPHOBICITY; INTERNALIZATION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANIMALS; CELL LINE; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; HUMANS;

EID: 77958150407     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.02.027     Document Type: Article

References (75)

1. Asimov I. Fantastic Voyage 1966, Bantam Books.
2. McNeil P.L. Direct introduction of molecules into cells. Curr. Protoc. Cell Biol. 2001, Chapter 20(Unit 20.1).
3. Cemazar M., Golzio M., Sersa G., Rols M.P., Teissié J. Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand?. Curr. Pharm. Des. 2006, 12:3817-3825.
4. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 2005, 4:145-160.
5. Whitehead K.A., Langer R., Anderson D.G. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug. Discov. 2009, 8:129-138.
6. Snyder E.L., Dowdy S.F. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. Expert Opin. Drug Deliv. 2005, 2:43-51.
7. Heitz F., Morris M.C., Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br. J. Pharmacol. 2009, 157:195-206.
8. Deshayes S., Morris M.C., Divita G., Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci. 2005, 62:1839-1849.
9. Morris M.C., Deshayes S., Heitz F., Divita G. Cell penetrating peptides: from molecular mechanisms to therapeutics. Biol. Cell 2008, 100:201-217.
10. Torchilin V.P. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv. Drug Deliv. Rev. 2008, 60:548-558.
11. Fonseca S.B., Pereira M.P., Kelley S.O. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv. Drug Deliv. Rev. 2009, 61:953-964.
12. Joliot A., Pernelle C., Deagostini-Bazin H., Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. USA 1991, 88:1864-1868.
13. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1998, 55:1189-1193.
14. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269:10444-10450.
15. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 1994, 91:664-668.
16. Vives E., Brodin P., Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 1997, 272:16010-16017.
17. kip1 induced cell migration. Nat. Med. 1998, 4:1449-1453.
18. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569-1572.
19. Gariepy J., Kawamura K. Vectorial delivery of macromolecules into cells using peptide-based vehicles. Trends Biotechnol. 2000, 19:21-28.
20. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., Rothbard J.B. The design, synthesis and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA 2000, 97:13003-13008.
21. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Suguira Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 2001, 276:5836-5840.
22. Pooga M., Hallbrink M., Zorko M., Langel Ü. Cell penetration by transportan. FASEB J. 1998, 15:1451-1453.
23. Morris M.C., Chaloin L., Heitz F., Divita G. Translocating peptides and proteins and their use for gene delivery. Curr. Opin. Biotechnol. 2000, 11:461-466.
24. Cartier R., Reska R. Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems. Gene Ther. 2002, 9:157-163.
25. Gait M.J. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell. Mol. Life Sci. 2003, 60:844-853.
26. Järver P., Langel U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov. Today 2004, 9:395-402.
27. El-Andaloussi S., Holm T., Langel Ü. Cell-penetrating peptides: mechanism and applications. Curr. Pharm. Des. 2005, 11:3597-3611.
28. Schwarze S.R., Hruska K.A., Dowdy S.F. Protein transduction: unrestricted delivery into all cells?. Trends Cell Biol. 2000, 10:290-295.
29. Wadia J.S., Dowdy S.F. Protein transduction technology. Curr. Opin. Biotechnol. 2002, 13:52-56.
30. G. Cao, W. Pei, H.Ge, Q. Liang, Y. Luo, F.R. Sharp, A. Lu, R. Ran, S.H. Graham, J. Chen, In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22 (2002) 5423-5431.
31. Niidome T., Huang L. Gene therapy progress and prospects: non viral vectors. Gene Ther. 2002, 10:1647-1652.
32. Joliot A., Prochiantz A. Transduction peptides: from technology to physiology. Nat. Cell Biol. 2004, 6:189-196.
33. Opalinska J.B., Gewirtz A.M. Nucleic-acid therapeutics: basic principles and recent applications. Nucleic-acid therapeutics: basic principles and recent applications. Nat. Rev. Drug Discov. 2002, 1:503-516.
34. Ogris M., Wagner E. Targeting tumors with non-viral gene delivery systems. Drug Discov. Today 2002, 7:479-485.
35. Gallo G. Making proteins into drugs: assisted delivery of proteins and peptides into living neurons. Methods Cell Biol. 2003, 71:325-338.
36. Gros E., Deshayes S., Morris M.C., Aldrian-Herrada G., Depollier J., Heitz F., Divita G. A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Biochim. Biophys. Acta 2006, 1758:384-393.
37. Morris M.C., Deshayes S., Simeoni F., Aldrian-Herrada G., Heitz F., Divita G. A noncovalent peptide-based strategy for peptide and short interfering RNA delivery. Cell-penetrating Peptides 2007, 387-408. CRC press, Boca Raton FL. Ü. Langel (Ed.).
38. Meade B.R., Dowdy S.F. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv. Drug Deliv. Rev. 2007, 59:134-140.
39. De Fougerolles A., Vornlocher H.-P., Maraganore J., Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discov. 2007, 6:443-453.
40. Pooga M., Soomets U., Hallbrink M., Valkna A., Saar K., Rezaei K., Kahl U., Hao J.X., Xu X.J., Wiesenfeld-Hallin Z., Hokfelt T., Bartfai T., Langel U. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 1998, 16:857-861.
41. Pooga M., Kut C., Kihlmark M., Hallbrink M., Fernaeus S., Raid R., Land T., Hallberg E., Bartfai T., Langel U. Cellular translocation of proteins by transportan. FASEB J. 2001, 15:1451-1453.
42. Schmidt M.C., Rothen-Rutishauser B., Rist B., Beck-Sickinger A., Wunderli-Allenspach H., Rubas W., Sadee W., Merkle H.P. Translocation of human calcitonin in respiratory nasal epithelium is associated with self assembly in lipid membrane. Biochemistry 1998, 37:16582-16590.
43. Krauss U., Muller M., Stahl M., Beck-Sickinger A.G. In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide. Bioorg. Med. Chem. Lett. 2004, 14:51-65.
44. Rennert R., Wespe C., Beck-Sickinger A.G., Neundorf I. Developing novel hCT derived cell-penetrating peptides with improved metabolic stability. Biochim. Biophys. Acta 2006, 1758:347-354.
45. Elliott Test G. Intercellular trafficking and protein delivery by a Herpesvirus structural protein. Cell 1997, 88:223-233.
46. Park C.B., Yi K.S., Matsuzaki K., Kim M.S., Kim S.C. Structure-activity analysis of buforin II, a histone 2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. USA 2000, 97:8245-8250.
47. Rousselle C., Smirnova M., Clair P., Lefauconnier J.M., Chavanieu A., Calas B., Scherrmann J.M., Temsamani J. Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. J. Pharmacol. Exp. Ther. 2001, 296:124-131.
48. Pujals S., Fernandez-Carneado J., Lopez-Iglesias C., Kogan M.J., Giralt E. Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly. Biochim. Biophys. Acta 2006, 1758:264-279.
49. Morris M.C., Vidal P., Chaloin L., Heitz F., Divita G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 1997, 25:2730-2736.
50. Morris M.C., Chaloin L., Mery J., Heitz F., Divita G. A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucleic Acids Res. 1999, 27:3510-3517.
51. Simeoni F., Morris M.C., Heitz F., Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 2003, 31:2717-2724.
52. Crombez L., Morris M.C., Dufort S., Aldrian-Herrada G., Nguyen Q., Mc Master G., Coll J.L., Heitz F., Divita G. Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res. 2009, 37:4559-4569.
53. Morris M.C., Depollier J., Mery J., Heitz F., Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 2001, 19:1173-1176.
54. Morris M.C., Chaloin L., Choob M., Archdeacon J., Heitz F., Divita G. The combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression. Gene Ther. 2004, 11:757-764.
55. Morris M.C., Gros E., Aldrian-Herrada G., Choob M., Archdeacon J., Heitz F., Divita G. A non-covalent peptide-based carrier for in vivo delivery of DNA mimics. Nucleic Acids Res. 2007, 35:e49-e59.
56. Crombez L., Aldrian-Herrada G., Konate K., Nguyen Q.N., Mc Master G.K., Brasseur R., Heitz F., Divita G. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol. Ther. 2009, 17:95-103.
57. Deshayes S., Heitz A., Morris M.C., Charnet P., Divita G., Heitz F. Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis. Biochemistry 2004, 43:1449-1457.
58. Deshayes S., Plénat T., Aldrian-Herrada G., Divita G., Le Grimellec C., Heitz F. Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes. Biochemistry 2004, 43:7698-7706.
59. Aoshiba K., Yokohori N., Nagai A. Alveolar wall apoptosis causes lung destruction and amphysematous changes. Am. J. Respir. Cell. Mol. Biol. 2003, 28:555-562.
60. Eum W.S., Kim D.W., Hwang I.K., Yoo K.Y., Kang T.C., Jang S.H., Choi H.S., et al. In vivo protein transduction: biologically active intact Pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic. Biol. Med. 2004, 37:1656-1669.
61. Maron M.B., Folkesson H.G., Stader S.M., Walro J.M. PKA delivery to the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced alveolar epithelial PKA desensitization. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:349-354.
62. Mattheakis L.C., Dias J.M., Choi Y.J., Gong J., Bruchez M.P., Liu J., Wang E. Optical coding of mammalian cells using semiconductor quantum dots. Anal. Biochem. 2004, 327:200-208.
63. Munoz M.A., Heitz F., Divita G., Morris M.C. The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes. Biochem. Biophys. Res. Commun. 2007, 355:877-882.
64. Deshayes S., Gerbal-Chaloin S., Morris M.C., Aldrian-Herrada G., Charnet P., Divita G., Heitz F. On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids. Biochim. Biophys. Acta 2004, 1667:141-147.
65. Deshayes S., Plénat T., Charnet P., Divita G., Molle G., Heitz F. Formation of transmembrane ionic channels of primary amphipathic cell-penetrating peptides. Consequences on the mechanism of cell penetration. Biochim. Biophys. Acta 2006, 1758:1846-1851.
66. Rittner K., Benavente A., Bompard-Sorlet A., Heitz F., Divita G., Brasseur R., Jacobs E. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol. Ther. 2002, 5:104-114.
67. Gottschalk S., et al. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther. 1996, 3:448-453.
68. Snyder E.L., Meade B.R., Dowdy S.F. Anti-cancer protein transduction strategies: restitution of p27 tumor suppressor function. J. Control. Release 2003, 91:45-51.
69. Morris M.C., Heitz A., Mery J., Heitz F., Divita G. An essential phosphorylation site domain of human cdc25C interacts with both 14-3-3 and cyclins. J. Biol. Chem. 2000, 275:28849-28857.
70. Boutros R., Lobjois V., Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets?. Nat. Rev. Cancer 2007, 7:495-507.
71. Boutros R., Dozier C., Ducommun B. The when and wheres of CDC25 phosphatases. Curr. Opin. Cell Biol. 2006, 18:185-191.
72. Campbell R.E., Tour O., Palmer A.E., Steinbach P.A., Baird G.S., Zacharias D.A., Tsien R.Y. A monomeric red fluorescent protein. Proc. Natl. Acad. Sci. USA 2002, 99:7877-7882.
73. D. Tempé, M. Brengues, P. Mayonove, H. Bensaad, C. Lacrouts, M.C. Morris, The alpha helix of ubiquitin interacts with yeast cyclin-dependent kinase subunit Cks1, Biochemistry 46 (2007) 45-54.
74. Brown N.R., Noble M.E., Lawrie A.M., Morris M.C., Tunnah P., Divita G., Johnson L.N., Endicott J.A. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. J. Biol. Chem. 1999, 274:8746-8756.
75. Gondeau C., Gerbal-Chaloin S., Bello P., Aldrian-Herrada G., Morris M.C., Divita G. Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation. J. Biol. Chem. 2005, 280:13793-13800.